Home › Atrial Fibrillation › New Jersey
Atrial Fibrillation clinical trials in New Jersey
12 studies for Atrial Fibrillation are looking for participants at sites in New Jersey.
Cities in New Jersey
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
- Cardiovascular Associates Of The Delaware Valley, Haddon Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06716021A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Capital Health Regional Medical Center, Trenton
Recruiting
Ages 22 and older · All sexes · Updated Nov 4, 2026 · NCT07227532A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- Rutgers Robert Wood Johnson Medical School, New Brunswick
Recruiting
Ages 18 to 80 · All sexes · Updated Nov 3, 2026 · NCT07523750The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
- Hackensack Meridian Health, Hackensack
- Rutgers, the State University of New Jersey, Piscataway
- and 1 more
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Nov 3, 2026 · NCT05836987A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Cooper University Hospital, Camden
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07217067Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
- The Valley Hospital, Paramus
RecruitingObservational study
Ages 21 and older · All sexes · Updated Oct 21, 2026 · NCT07275151Renal Denervation + PVI vs PVI Alone for Persistent AF
- University of Rochester, Short Hills
Recruiting
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05116384Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Cardiovascular Associates of the Delaware Valley, Haddon Heights
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- Hackensack University Medical Center, Hackensack
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigational Site 9807, Elmer
- Anthos Investigational site 9801, Sewell
- Anthos Investigational site 9963, Somerset
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Jersey Shore University Medical Center, Neptune City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT04045665Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- JFK Medical Center, Edison
- Hackensack University Medical Center, Hackensack
- Cooperman Barnabas Medical Center, Livingston
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.